Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Naltrexone for Improved Medication Compliance Among HIV-infected Men With Alcohol Use Disorder

NCT01377168 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT01377168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01377168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Naltrexone for Improved Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2014
Completion date
June 30, 2017
Enrollment
159 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, hiv